Expression of NF-κB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy

Radiology and Oncology

Volumn 45, Issue 4, 2011, Pages 279-284

  Lewander, Andreas ^a   Gao, Jinfang ^a   Adell, Gunnar ^b   Zhang, Hong ^c   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

immunohistochemistry; NF B; prognosis; radiotherapy; rectal cancer; recurrence; serine 536

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MENINGIOMA ASSOCIATED PROTEIN; PHOSPHATASE; PHOSPHATASE OF REGENERATING LIVER; PROTEIN FXYD 3; PROTEIN TYROSINE PHOSPHATASE; SERINE; SYNAPTOTAGMIN I; TUMOUR ENDOTHELIUM MARKER 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE CARE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; RECTUM CANCER; RECTUM CARCINOMA; RECTUM MUCOSA; RECTUM RESECTION; RECURRENT CANCER;

EID: 81755171096     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-011-0030-7     Document Type: Article

References (30)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
2. Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589-92.
3. Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007; 22: 1387-98. (Pubitemid 47470331)
4. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phos-phorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999; 274: 30353-6.
5. Viatour P, Merville MP, Bours V, Chariot Al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52. (Pubitemid 40093740)
6. Miyakoshi J, Yagi K, Inhibition of IκB-α phosphorylation at serine and tyro-sine acts independently on sensitization to DNA damaging agents in human glioma cells. Br J Cancer 2000; 82: 28-33. (Pubitemid 30008954)
7. Yamagashi N, Miyakoshi J, Takebe H. Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. Int J Radiat Biol 1997; 72: 157-62. (Pubitemid 27339410)
8. Velenik V, Oblak I; Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study. Radiol Oncol 2008; 42: 207-14.
9. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. New Eng J Med 1997; 336: 980-7.
10. Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009; 43: 144-51.
11. Loftås P, Önnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, et al. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 137-42.
12. Pfeifer D, Gao J, Adell G, Sun X-F. Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 1143-8.
13. Wallin Å, Svanvik J, Adell G, Sun X-F. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 452-8.
14. Zhang Z Y, Zhao ZR, Adell G, Jarlstelt I, Cul YX, Kayed H, et al. MAC30 in rectal cancers with or without preoperative radiotherapy. Oncology 2006; 71: 259-65.
15. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-κB is upregulated in colorectal cancer. Surgery 2001; 130: 363-9. (Pubitemid 32721692)
16. Yu HG, Yu LL, Yang Y, LuoH-S, Yu J-P, MeierJJ, et al. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigen-esis. Oncology 2003; 65: 37-45. (Pubitemid 36829089)
17. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, et al. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94. (Pubitemid 351282034)
18. MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregu-lated during development. Gene Expr Patterns 2007; 7: 363-69. (Pubitemid 44835271)
19. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. Proc Natl Acad Sci (USA) 2007; 104: 17965-70. (Pubitemid 350210804)
20. Morrison BW, Moorman JR, Kowdley GC, Kobayashi YM, Jones LR, Leder P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem 1995; 270: 2176-82.
21. Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, et al. FXYD3 is over-expressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 2006; 118: 43-54. (Pubitemid 41681579)
22. Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma. Radiol Oncol 2009; 43: 1-8.
23. Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD, et al. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003;15:5607-15. (Pubitemid 37499481)
24. Sager JA, Benvenuti S, Bardelli A: PRL-3: a phosphatase for metastasis? Cancer Biol Ther 2004;3:952-3. (Pubitemid 41351017)
25. Bénard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 2003;21:182-91. (Pubitemid 36292961)
26. Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res. 2002;8:165-70.
27. Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, et al. Identification of differentially expressed mRNAs in human fetal liver across gestation. Nucleic Acids Res 1999;27:839-47. (Pubitemid 29209373)
28. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 1993;4:715-22.
29. Moparthi S, Arbman G, Wallin Å, Kayed H, Kleeff J, Zentgraf H, et al. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int J Oncol 2007;30:91-5.
30. Kayed H, Kleeff J, Ding J, Hammer J, Giese T, Zentgraf H, et al. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol Histopathol 2004;19:1021-31. (Pubitemid 39386761)